Molecular and functional characterization of organic cation/carnitine transporter family in mice
about
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human geneticsL-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognitionDiscovery of the ergothioneine transporterStrategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamilyTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cellsFunctional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiencyCaveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytesIncreased maternal consumption of methionine as its hydroxyl analog promoted neonatal intestinal growth without compromising maternal energy homeostasisA moderate excess of dietary lysine lowers plasma and tissue carnitine concentrations in pigs.PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis.Dietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats.Mammalian Glucose Transporter Activity Is Dependent upon Anionic and Conical PhospholipidsThe promise and perils of interpreting genetic associations in Crohn's disease.Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier.Active efflux across the blood-brain barrier: role of the solute carrier family.Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidationThe human carnitine transporter SLC22A16 mediates high affinity uptake of the anticancer polyamine analogue bleomycin-A5Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier.Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation.Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transporters.Mechanisms and clinical implications of renal drug excretion.Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathyReduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive ratsTranscriptional regulation of the human, porcine and bovine OCTN2 gene by PPARα via a conserved PPRE located in intron 1.Pharmacological doses of niacin stimulate the expression of genes involved in carnitine uptake and biosynthesis and improve the carnitine status of obese Zucker rats.Drug transporters, the blood-testis barrier, and spermatogenesisGenotype-phenotype correlation in primary carnitine deficiencyDrug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsMolecular and cellular physiology of renal organic cation and anion transport.Systematic Evaluation of Key L-Carnitine Homeostasis Mechanisms during Postnatal Development in RatInhibition of OCTN2-mediated transport of carnitine by etoposide.Metabolite transport across the peroxisomal membrane.Complex genomic rearrangement in CCS-LacZ transgenic mice.Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter.Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition.Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency.
P2860
Q21131205-964033AE-4F61-4DDB-9E9A-DDD4C19EB93AQ24298663-FE7CB49C-2E1E-432F-A7C9-FC4B30807B04Q24300520-0A9D0097-8BB4-4D5D-A958-AD65074081F9Q24555734-BD362ED3-4887-41D6-8554-5977E8734928Q27010565-F65F7965-36FC-47DE-B93A-330403600699Q27690256-BCBAC631-09D3-41F1-BEC2-E6138D848E1FQ28189745-BC415935-BAA7-4B0F-A58D-BE5FED40F136Q28204696-46B5C559-588B-4E5E-BD5B-25DF4126DB5FQ28537671-0950C065-E887-4C12-97AD-EAF4DB65CE79Q28598187-6E8F59B4-E5D6-4F55-AD32-26D0E4915665Q30319573-53700396-369D-4869-8B59-66EB1346D0D3Q30319665-37DE75E0-AFF6-4ED1-B7A8-3179F2338290Q30319820-957E478E-3BE1-4EF3-B73C-DD145112C62CQ30389284-438DC4DD-C31C-4AF6-8F2F-123DF40D0E82Q30441075-FE094261-E063-44DF-8291-8FF89D0A3B98Q30837035-0F48CE41-F51E-4EA6-8B2E-E51CA995D8D8Q33569358-630CBC11-E4D2-4411-899A-2B0668900FD5Q33633988-8A50F870-2825-48EE-8C10-F0A75E0C0450Q33673595-0FC4E237-8823-4ABE-AA83-A9A2D79E7B06Q33714593-17451D95-ABD1-428E-A3F9-8A89ECE02931Q33956337-79DC3B00-2E4D-457C-B8BA-A887B73C8467Q33985125-DDB1B2D2-80A5-4164-8A52-132B6CEF1026Q34305376-0EC4EC41-57E4-4B45-9DDD-11F54F86CA78Q34309854-DE781D0D-E9E5-4F86-AA86-1E2F4DC04721Q34479011-3C7A317E-B4EA-4254-A05C-C54E3A7BD9A8Q35071386-FCB3D33E-3CE6-4B0A-A23F-08E41BAB7A8EQ35108977-46231D5C-2A8B-429B-8774-45FBB0B5F7E5Q35189069-244BC340-EB15-41EE-A8F3-406656AA8B6CQ35204914-EB314DFD-FF23-4D3C-B49C-D3124B04C414Q35240133-38BE71A8-8AE7-442E-AA70-E2B75E8389ADQ35618853-DFB93087-AAF6-4BD5-AADB-E765526C6C89Q35795744-6D5EC9CA-4E33-43E1-972C-1DD47DF4256BQ35842999-CBDF002C-BF02-4A8E-8B83-CA67EE533A54Q36127673-E3A5DBD3-5BD2-4100-83BC-D8ECB6F4D815Q36302949-D4950A65-4F70-4902-BEE4-0147DF018A58Q36686087-40E97F53-E5E1-43F3-B5D7-BA7035533C1AQ36793748-BF255F54-71A2-4391-809F-D5318BA9917EQ36817792-FDBA9693-DB9F-495E-9881-6B4814D611EBQ37834510-AFB70917-EEE3-47BA-BED1-86A5105FAD75Q37963740-ECFD7605-3FBE-48ED-9385-C0F919E5638D
P2860
Molecular and functional characterization of organic cation/carnitine transporter family in mice
description
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2000
@ast
im Dezember 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/12/22)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/12/22)
@nl
наукова стаття, опублікована в грудні 2000
@uk
name
Molecular and functional chara ...... ine transporter family in mice
@ast
Molecular and functional chara ...... ine transporter family in mice
@en
Molecular and functional chara ...... ine transporter family in mice
@nl
type
label
Molecular and functional chara ...... ine transporter family in mice
@ast
Molecular and functional chara ...... ine transporter family in mice
@en
Molecular and functional chara ...... ine transporter family in mice
@nl
prefLabel
Molecular and functional chara ...... ine transporter family in mice
@ast
Molecular and functional chara ...... ine transporter family in mice
@en
Molecular and functional chara ...... ine transporter family in mice
@nl
P2093
P2860
P3181
P356
P1476
Molecular and functional chara ...... ine transporter family in mice
@en
P2093
D. Kobayashi
J. I. Nezu
M. Shimane
P2860
P304
40064–40072
P3181
P356
10.1074/JBC.M005340200
P407
P577
2000-12-22T00:00:00Z